RS63292B1 - Inflamatorni biomarkeri za predviđanje responsivnosti na jedinjenje fgf-18 - Google Patents
Inflamatorni biomarkeri za predviđanje responsivnosti na jedinjenje fgf-18Info
- Publication number
- RS63292B1 RS63292B1 RS20220541A RSP20220541A RS63292B1 RS 63292 B1 RS63292 B1 RS 63292B1 RS 20220541 A RS20220541 A RS 20220541A RS P20220541 A RSP20220541 A RS P20220541A RS 63292 B1 RS63292 B1 RS 63292B1
- Authority
- RS
- Serbia
- Prior art keywords
- fgf
- compound
- predicting responsiveness
- inflammatory biomarkers
- biomarkers
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17194169 | 2017-09-29 | ||
| EP18169317 | 2018-04-25 | ||
| PCT/EP2018/076391 WO2019063756A1 (en) | 2017-09-29 | 2018-09-28 | INFLAMMATORY BIOMARKERS FOR PREDICTING REACTIVITY TO FGF-18 COMPOUND |
| EP18782012.1A EP3688468B1 (en) | 2017-09-29 | 2018-09-28 | Inflammatory biomarkers for predicting responsiveness to fgf-18 compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS63292B1 true RS63292B1 (sr) | 2022-06-30 |
Family
ID=63722379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20220541A RS63292B1 (sr) | 2017-09-29 | 2018-09-28 | Inflamatorni biomarkeri za predviđanje responsivnosti na jedinjenje fgf-18 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11467169B2 (sr) |
| EP (1) | EP3688468B1 (sr) |
| JP (1) | JP7418324B2 (sr) |
| CN (1) | CN111164429A (sr) |
| AU (1) | AU2018343980A1 (sr) |
| CA (1) | CA3075713A1 (sr) |
| DK (1) | DK3688468T3 (sr) |
| ES (1) | ES2918249T3 (sr) |
| HR (1) | HRP20220737T1 (sr) |
| HU (1) | HUE058848T2 (sr) |
| IL (1) | IL273574A (sr) |
| LT (1) | LT3688468T (sr) |
| PL (1) | PL3688468T3 (sr) |
| RS (1) | RS63292B1 (sr) |
| SI (1) | SI3688468T1 (sr) |
| WO (1) | WO2019063756A1 (sr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3687558T (lt) | 2017-09-29 | 2022-06-27 | Merck Patent Gmbh | Metaboliniai biožymenys, skirti atsako į fgf-18 junginį numatymui |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9712348B1 (pt) | 1996-10-16 | 2013-06-18 | vetor de expressão, célula de bactéria ou levedura transformada ou transfectada, processo para produzir um polipeptídeo homólogo de fgf, composição farmacêutica, e, processos para estimular ex vivo células progenitoras de miócitos ou miócitos | |
| US20040136970A1 (en) | 2002-10-07 | 2004-07-15 | Ellsworth Jeff L. | Methods for administering FGF18 |
| PT1828239E (pt) | 2004-12-10 | 2011-10-27 | Zymogenetics Inc | Produção de fgf18 em hospedeiros procarióticos |
| JP5815206B2 (ja) | 2006-08-25 | 2015-11-17 | アレス トレーディング ソシエテ アノニム | Ｆｇｆ−１８を用いた軟骨障害の治療 |
| AU2013301606B2 (en) | 2012-08-06 | 2018-08-02 | Merck Patent Gmbh | Genetic markers for predicting responsiveness to FGF-18 compound |
| WO2015084883A2 (en) * | 2013-12-02 | 2015-06-11 | Abbvie, Inc. | Compositions and methods for treating osteoarthritis |
| SG11201606505UA (en) * | 2014-02-20 | 2016-09-29 | Merck Patent Gmbh | Fgf-18 compound dosing regimen |
| LT3687558T (lt) | 2017-09-29 | 2022-06-27 | Merck Patent Gmbh | Metaboliniai biožymenys, skirti atsako į fgf-18 junginį numatymui |
-
2018
- 2018-09-28 CN CN201880063173.4A patent/CN111164429A/zh active Pending
- 2018-09-28 JP JP2020517797A patent/JP7418324B2/ja active Active
- 2018-09-28 SI SI201830693T patent/SI3688468T1/sl unknown
- 2018-09-28 DK DK18782012.1T patent/DK3688468T3/da active
- 2018-09-28 ES ES18782012T patent/ES2918249T3/es active Active
- 2018-09-28 WO PCT/EP2018/076391 patent/WO2019063756A1/en unknown
- 2018-09-28 PL PL18782012.1T patent/PL3688468T3/pl unknown
- 2018-09-28 EP EP18782012.1A patent/EP3688468B1/en active Active
- 2018-09-28 LT LTEPPCT/EP2018/076391T patent/LT3688468T/lt unknown
- 2018-09-28 CA CA3075713A patent/CA3075713A1/en active Pending
- 2018-09-28 AU AU2018343980A patent/AU2018343980A1/en active Pending
- 2018-09-28 HU HUE18782012A patent/HUE058848T2/hu unknown
- 2018-09-28 US US16/650,878 patent/US11467169B2/en active Active
- 2018-09-28 RS RS20220541A patent/RS63292B1/sr unknown
- 2018-09-28 HR HRP20220737TT patent/HRP20220737T1/hr unknown
-
2020
- 2020-03-24 IL IL273574A patent/IL273574A/en unknown
-
2022
- 2022-09-01 US US17/929,261 patent/US20230258659A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210231680A1 (en) | 2021-07-29 |
| SI3688468T1 (sl) | 2022-08-31 |
| JP7418324B2 (ja) | 2024-01-19 |
| PL3688468T3 (pl) | 2022-07-18 |
| HUE058848T2 (hu) | 2022-09-28 |
| DK3688468T3 (da) | 2022-06-20 |
| JP2020535423A (ja) | 2020-12-03 |
| EP3688468A1 (en) | 2020-08-05 |
| CA3075713A1 (en) | 2019-04-04 |
| US20230258659A1 (en) | 2023-08-17 |
| US11467169B2 (en) | 2022-10-11 |
| LT3688468T (lt) | 2022-06-27 |
| EP3688468B1 (en) | 2022-03-16 |
| HRP20220737T1 (hr) | 2022-09-02 |
| AU2018343980A1 (en) | 2020-04-02 |
| WO2019063756A1 (en) | 2019-04-04 |
| ES2918249T3 (es) | 2022-07-14 |
| CN111164429A (zh) | 2020-05-15 |
| IL273574A (en) | 2020-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201609977D0 (en) | Chemosensitivity predictive biomarkers | |
| GB2511949B (en) | Indirect branch prediction | |
| GB2510966B (en) | Indirect branch prediction | |
| GB201320216D0 (en) | Predicting call quality | |
| GB201402293D0 (en) | Biomarker signatures for the prediction of onset of sepsis | |
| HUE058197T2 (hu) | Biomarkerek gyulladásos bélbetegséghez | |
| IL273613A (en) | Metabolic biomarkers for predicting response to FGF-18 compound | |
| IL273840A (en) | Biomarker for senescent cells | |
| GB201704267D0 (en) | Novel biomarker | |
| EP3036712A4 (en) | Methods for predicting prognosis | |
| IL241063A0 (en) | Observe for predictive biomarkers | |
| GB201705044D0 (en) | Biomarker | |
| ZA201706684B (en) | Beta-hairpin peptidomimetics | |
| GB201500729D0 (en) | Novel Biomarkers | |
| IL273574A (en) | Inflammatory biomarkers for predicting response to FGF-18 compound | |
| EP2963114A4 (en) | METHOD FOR PREDICTING REACTIVITY TO A COMPOUND INHIBITING THE MAPK SIGNAL TRANSDUCTION PATHWAY | |
| GB201306339D0 (en) | Biomarkers for prognosis | |
| PT3688468T (pt) | Biomarcadores inflamatórios para prever a recetividade ao composto de fg-18 | |
| FR3033460B1 (fr) | Ensemble de refroidissement pour aeronef | |
| PT3687558T (pt) | Biomarcadores metabólicos para prever a responsividade ao composto de fgf-18 | |
| EP2990087A4 (en) | DEPRESSOR OF DETERIORATION OF AN OIL | |
| DK3401310T3 (da) | Phenylimidazolforbindelse | |
| GB201603002D0 (en) | Inflammation biomarker | |
| GB201603263D0 (en) | Biomarkers for response to bip (rasolvir) | |
| GB201714220D0 (en) | Biomarkers for predicting response to clostridium difficile |